跳至主要内容
临床试验/NCT03294226
NCT03294226已完成不适用

A Randomized Trial of Ambu® AuraGain™ Versus I-gel® in Young Children

Asan Medical Center2 个研究点 分布在 1 个国家目标入组 68 人开始时间: 2017年9月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
68
试验地点
2
主要终点
requirement of additional airway maneuver

研究概览

简要总结

Children from 6 months to 6 years are randomly allocated into AuraGain group or I-gel group. After anesthetic induction without neuromuscular blocking agent, assigned device in inserted by skillful anesthesiologist. The outcome measures are recorded and analysed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
6 Months 至 6 Years(Child)
性别
All
接受健康志愿者

入选标准

  • ASA physical status: 1-3
  • age: from 6 months to 6 year
  • body weight: 5-20kg
  • patients undergoing upper/lower extremity surgery at supine position

排除标准

  • patients who do not want to participate in this study
  • patients with known difficult airway including congenital facial anomaly or history of difficult airway management
  • patients with aspiration risk (gastrointestinal stenosis or stricture)
  • patients with symptom of upper respiratory infection on the day of surgery
  • patients scheduled for day surgery
  • patients judged as not eligible by researchers for other reasons

研究组 & 干预措施

AuraGain

Experimental

After anesthetic induction, AuraGain is inserted for airway management. Size of the device is selected according to the manufacturer's recommendation; size 1.5 for 5-10kg, size 2 for 10-20kg.

干预措施: AuraGain (Device)

I-gel

Active Comparator

After anesthetic induction, I-gel is inserted for airway management. Size of the device is selected according to the patient's weight; size 1.5 for 5-10kg, size 2 for 10-20kg.

干预措施: I-gel (Device)

结局指标

主要结局

requirement of additional airway maneuver

时间窗: during placement/maintenance of the device

including adjustment of head/neck position or insertion depth and taping of the device

次要结局

  • insertion time(during placement of the device)
  • ease of gastric tube insertion(within 10 minutes after device insertion)
  • adverse effect at operating room(during anesthesia)
  • postoperative adverse effect(within postoperative 24 hours)
  • oropharyngeal leak pressure(at 1 minute after device insertion, at 10 minutes after device insertion)
  • fiberoptic view of glottis(within 10 minutes after device insertion)
  • success rate(during placement of the device)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hajung Kim

Clinical Instructor

Asan Medical Center

研究点 (2)

Loading locations...

相似试验

Comparison of AuraGain With I-gel for Pediatric... | 临床试验